Actively Recruiting
Study of Minocyclines Effectiveness and Safety in Adults Aged 18 to 80 With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
Led by Beijing Tiantan Hospital · Updated on 2026-07-01
934
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the efficacy and safety of minocycline, an antibiotic with protective properties beyond its antibacterial action, in improving functional outcomes for patients with acute ischaemic stroke who receive intravenous thrombolysis. This phase 3, multicenter, randomized, double-blind, placebo-controlled trial aims to see if minocycline can enhance recovery by targeting neuroinflammation after stroke. Prior trials suggest minocycline, started within hours of stroke, may improve outcomes and reduce complications when combined with thrombolytic therapy. Participants aged 18 to 80 years with recent ischaemic stroke who have received or will receive intravenous thrombolysis within 4.5 hours or an extended 4.5 to 24-hour window will be randomly assigned to receive either minocycline capsules or placebo. The study drug is given as a 200 mg loading dose before or within 2 hours after thrombolysis, followed by 100 mg every 12 hours for 4 days, totaling nine doses. Capsules may be taken orally or via a feeding tube if swallowing is difficult. During the study, participants will be assessed at screening, 6 days, 30, 60, and 90 days after randomization. Researchers will monitor functional outcomes using scales like the modified Rankin Scale, NIH Stroke Scale, and quality of life measures, as well as record safety outcomes including bleeding events and gastrointestinal side effects. The primary outcome is excellent functional recovery at 90 days. The study will last until the end of 2028, with careful follow-up to evaluate both benefits and risks.
CONDITIONS
Brief Title
Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
Research Team
A
Anxin Wang, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here